Rich Olofson has over 30 years of financial operations and management experience in the biotechnology sector. Most recently, he was the Director of Corporate Finance for Novozymes where he led the accounting and financial reporting functions for 13 legal entities spread across 5 countries in North and South America. Rich received his MBA from the Kenan-Flagler Business School, University of North Carolina at Chapel Hill, after majoring in Finance and Accounting as an undergraduate at the Wharton School of the University of Pennsylvania. He is a Certified Management Accountant.